Role of mTOR inhibitor in cholangiocarcinoma cell progression
Penpak Moolthiya(Mahidol University), Kawin Leelawat(Rajavithi Hospital)
Cited by 29
Related Papers
Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
|Cancer Cell International|2009|43